TUDCA (Tauroursodeoxycholic Acid)

Oral capsule (250mg)Available in all 50 states

Marketing purposes only. Actual medications, if prescribed, are dispensed by a licensed pharmacy.

heart

TUDCA (Tauroursodeoxycholic Acid)TUDCA (Tauroursodeoxycholic Acid)

Taurine conjugate of UDCA with greater cytoprotection and bioavailability. Uniquely functions as an ER stress inhibitor (chemical chaperone) with demonstrated neuroprotective and insulin-sensitizing effects beyond liver protection.

Potent ER stress inhibition (unique)

Greater hepatocyte protection than UDCA

Insulin sensitization via ER stress reduction

Neuroprotective across multiple models

No commitment · HSA/FSA eligibleNo commitment · HSA/FSA eligible

How it works

Mechanism of action

Shares UDCA mechanisms plus potent chemical chaperone activity, stabilizes misfolded proteins, facilitates proper folding, and attenuates the unfolded protein response (UPR). Reduces ER stress which drives T2DM, neurodegeneration, and NASH.

The baseline panel.

Every Marek client receives this baseline panel before a provider review. Your provider may add additional biomarkers based on your health history, symptoms, and goals, pulling from 1,000+ available markers. See more biomarkers →

Hormone Profile

12 markers

Sex hormones

  • Total TestosteroneLC/MS
  • Free TestosteroneEquilibrium Dialysis
  • Estradiol, Sensitive / UltrasensitiveLC/MS
  • Sex Hormone Binding Globulin (SHBG)
  • ProgesteroneLC/MSFemale panel
  • Prolactin
  • Luteinizing Hormone (LH)
  • Follicle-Stimulating Hormone (FSH)
  • hCG, Total, QuantitativeFemale panel, pre-menopause

Adrenals & neurosteroids

  • Cortisol
  • DHEA-S

Growth hormone / IGF-1

  • Insulin-Like Growth Factor I (IGF-1)

Thyroid Status

3 markers

Thyroid hormones

  • Thyroid Stimulating Hormone (TSH)
  • Free T4
  • Free T3

Heart Health

9 markers

Cardiovascular health

  • Total Cholesterol
  • HDL Cholesterol
  • LDL Cholesterol
  • LDL:HDL Ratio
  • VLDL Cholesterol
  • Triglycerides
  • Apolipoprotein-B (ApoB)
  • C-Reactive Protein, High Sensitivity (hsCRP)
  • Lipoprotein(a) (Lp(a))

Metabolism

3 markers

Insulin sensitivity

  • Blood Glucose
  • Fasting Insulin
  • HbA1c

Organ Function

26 markers

Liver & pancreas

  • AST
  • ALT
  • Bilirubin, Total
  • γ-Glutamyl Transferase (GGT)

Kidney function

  • BUN
  • Creatinine w/ eGFR

Comprehensive Metabolic Panel (CMP)

  • Glucose
  • Blood Urea Nitrogen (BUN)
  • Creatinine
  • eGFR
  • BUN/Creatinine Ratio
  • Sodium
  • Potassium
  • Chloride
  • Carbon Dioxide, Total
  • Calcium
  • Protein, Total
  • Albumin
  • Globulin, Total
  • Albumin/Globulin (A/G) Ratio
  • Alkaline Phosphatase (ALP)
  • AST
  • ALT

Prostate health

  • Prostate-Specific Antigen (PSA)Male panel
  • Free PSAMale panel
  • % Free PSAMale panel

Nutrient Status

31 markers

Vitamins & minerals

  • Vitamin D, 25-OHD (25-Hydroxy)
  • Magnesium, RBC

Iron status

  • Iron
  • Iron Saturation
  • TIBC
  • UIBC
  • Ferritin

Complete Blood Count (CBC)

  • White Blood Count (WBC)
  • Red Blood Count (RBC)
  • Hemoglobin (Hgb)
  • Hematocrit (HCT)
  • MCV
  • MCH
  • MCHC
  • Red Cell Distribution Width (RDW)
  • Platelets
  • Neutrophils
  • Neutrophils (Absolute)
  • Lymphocytes
  • Lymphocytes (Absolute)
  • Neutrophil/Lymphocyte Ratio
  • Monocytes
  • Monocytes (Absolute)
  • Eosinophils
  • Eosinophils (Absolute)
  • Basophils
  • Basophils (Absolute)
  • Immature Cells
  • Immature Granulocytes
  • Immature Granulocytes (Absolute)
  • NRBC, w/ Reflex for Immature Cells

Clinical evidence

The research behind TUDCA (Tauroursodeoxycholic Acid).

TUDCA Reduces ER Stress and Reverses Hepatic Insulin Resistance

Science (2006)

Reversed ER stress, restored insulin signaling, normalized glucose in obese insulin-resistant mice.

TUDCA Is Neuroprotective in the SOD1 ALS Model

Nature (2007)

Delayed disease onset, extended survival, and preserved motor neurons in ALS mice.

Safety profile

Monitoring & safety information.

Commonly reported side effects

  • GI discomfort (less than UDCA)
  • Loose stools
  • Nausea (rare)

Less common but serious risks

  • Limited long-term human safety data beyond liver indication

Generally not appropriate for

  • Bile duct obstruction
  • Acute cholecystitis
  • Pregnancy

Typical monitoring

  • Liver function tests
  • GI symptoms
  • HbA1c (if used for insulin sensitization)

FAQ

Quick answers.

Taurine conjugate of UDCA with greater cytoprotection and bioavailability. Uniquely functions as an ER stress inhibitor (chemical chaperone) with demonstrated neuroprotective and insulin-sensitizing effects beyond liver protection.
Potent ER stress inhibition (unique). Greater hepatocyte protection than UDCA. Insulin sensitization via ER stress reduction. Neuroprotective across multiple models.
Common side effects include: gi discomfort (less than udca), loose stools, nausea (rare). Most side effects are dose-dependent and may resolve with continued use or dose adjustment.
View all FAQs
See all FAQs

Taurine conjugate of UDCA with greater cytoprotection and bioavailability. Uniquely functions as an ER stress inhibitor (chemical chaperone) with demonstrated neuroprotective and insulin-sensitizing effects beyond liver protection.

Treatments are dependent on licensed clinical prescription. Client costs vary based on individual labs and panel in treatments and services.